Black Rock Inc. Theravance Biopharma, Inc. Transaction History

Black Rock Inc.

$4.35 Trillion
Q2 2024

A detailed history of Black Rock Inc. transactions in Theravance Biopharma, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 3,780,160 shares of TBPH stock, worth $35.4 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,780,160

Previous 4,208,337 10.17%

Holding current value

$35.4 Million

Previous $37.7 Million 15.08%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	SELL	$8.29 - $9.92 $3.55 Million - $4.25 Million	-428,177 Reduced 10.17%	3,780,160 $32.1 Million
Q1 2024 May 10, 2024	SELL	$8.22 - $11.59 $3.12 Million - $4.4 Million	-379,497 Reduced 8.27%	4,208,337 $37.7 Million
Q4 2023 Feb 13, 2024	BUY	$8.58 - $11.4 $179,356 - $238,305	20,904 Added 0.46%	4,587,834 $51.6 Million
Q3 2023 Nov 13, 2023	SELL	$8.38 - $10.44 $4.31 Million - $5.37 Million	-514,285 Reduced 10.12%	4,566,930 $39.4 Million
Q2 2023 Aug 11, 2023	SELL	$10.16 - $11.92 $624,453 - $732,627	-61,462 Reduced 1.2%	5,081,215 $52.6 Million
Q1 2023 May 12, 2023	SELL	$9.87 - $11.44 $1.86 Million - $2.15 Million	-188,100 Reduced 3.53%	5,142,677 $55.8 Million
Q4 2022 Feb 13, 2023	BUY	$9.65 - $11.34 $2.15 Million - $2.53 Million	223,250 Added 4.37%	5,330,777 $59.8 Million
Q3 2022 Nov 14, 2022	BUY	$8.39 - $10.22 $711,362 - $866,523	84,787 Added 1.69%	5,107,527 $51.8 Million
Q2 2022 Aug 12, 2022	BUY	$8.41 - $10.34 $787,176 - $967,824	93,600 Added 1.9%	5,022,740 $45.5 Million
Q1 2022 May 12, 2022	SELL	$8.33 - $12.96 $609,947 - $948,970	-73,223 Reduced 1.46%	4,929,140 $47.1 Million
Q4 2021 Feb 10, 2022	SELL	$7.42 - $11.05 $757,552 - $1.13 Million	-102,096 Reduced 2.0%	5,002,363 $55.3 Million
Q3 2021 Nov 09, 2021	BUY	$6.77 - $14.41 $3.95 Million - $8.41 Million	583,752 Added 12.91%	5,104,459 $37.8 Million
Q2 2021 Aug 11, 2021	BUY	$14.52 - $22.46 $65.6 Million - $102 Million	4,520,707 New	4,520,707 $65.6 Million

Others Institutions Holding TBPH

# of Institutions

123

Shares Held

47.3M

Call Options Held

200

Put Options Held

12.8K

View Full List

About Theravance Biopharma, Inc.

Ticker TBPH
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 66,782,400
Market Cap $625M
Description
Theravance Biopharma, Inc., a biopharmaceutical company, discovers, develops, and commercializes respiratory medicines in the United States, Europe, and Asia. The company offers YUPELRI, a once-daily, nebulized long-acting muscarinic antagonist used for the treatment of chronic obstructive pulmonary disease (COPD). Its product portfolio also inc...

More about TBPH

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account